Related Experiment Video
Updated: Oct 6, 2025

Analysis of Translation Initiation During Stress Conditions by Polysome Profiling
Published on: May 19, 2014
Disorder at the Start: The Contribution of Dysregulated Translation Initiation to Cancer Therapy Resistance
1Department of Biochemistry and Molecular Biology, Louisiana State University Health and Feist Weiller Cancer Center, Shreveport, LA, United States.
Abstract:
Translation of cellular RNA to protein is an energy-intensive process through which synthesized proteins dictate cellular processes and function. Translation is regulated in response to extracellular effectors and availability of amino acids intracellularly. Most eukaryotic mRNA rely on the methyl 7-guanosine (m7G) nucleotide cap to recruit the translation machinery, and the uncoupling of translational control that occurs in tumorigenesis plays a significant role in cancer treatment response. This article provides an overview of the mammalian translation initiation process and the primary mechanisms by which it is regulated. An outline of how deregulation of initiation supports tumorigenesis and how initiation at a downstream open reading frame (ORF) of Tousled-like kinase 1 (TLK1) leads to treatment resistance is discussed.
Insights
Cellular RNA translation into protein is regulated and essential for cell function. Deregulation of this process, particularly at the Tousled-like kinase 1 (TLK1) gene, contributes to cancer and treatment resistance.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- Cellular RNA translation into protein is a fundamental, energy-intensive process.
- This translation is tightly regulated by extracellular signals and intracellular amino acid availability.
- The 5' methyl 7-guanosine (m7G) cap is crucial for mRNA recruitment of the translation machinery in eukaryotes.
Purpose of the Study:
- To provide an overview of mammalian translation initiation.
- To discuss the primary regulatory mechanisms of translation.
- To explore how deregulation of translation initiation contributes to tumorigenesis and treatment resistance, focusing on TLK1.
Main Methods:
- Literature review of mammalian translation initiation.
- Analysis of regulatory mechanisms governing translation.
- Discussion of the role of aberrant translation initiation in cancer, specifically TLK1 downstream ORF initiation.
Main Results:
- Translation initiation is a key regulatory point in gene expression.
- Dysregulation of translation initiation is implicated in cancer development.
- Initiation at a downstream open reading frame (ORF) of Tousled-like kinase 1 (TLK1) is linked to cancer treatment resistance.
Conclusions:
- Understanding translation initiation regulation is vital for cancer biology.
- Aberrant translation control, exemplified by TLK1, represents a significant mechanism in tumorigenesis and therapeutic failure.
- Targeting translation initiation pathways may offer novel cancer treatment strategies.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Treatment Resistant Cancers
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Leaky Scanning
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

